Ser350
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser350  -  DRAK2 (rat)

Site Information
PEDDSLLsKRFRFDD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1735800

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 )
Disease tissue studied:
colorectal cancer ( 1 )
Relevant cell line - cell type - tissue:
ACL-15 (intestinal) ( 1 ) , COS (fibroblast) ( 1 )

Upstream Regulation
Putative in vivo kinases:
PKCG (human) ( 1 )
Kinases, in vitro:
PKCG (human) ( 1 )
Treatments:
phorbol_ester ( 1 ) , UV ( 1 )

Downstream Regulation
Effects of modification on DRAK2:
intracellular localization ( 1 )

References 

1

Kuwahara H, Nishizaki M, Kanazawa H (2008) Nuclear localization signal and phosphorylation of Serine350 specify intracellular localization of DRAK2. J Biochem 143, 349-58
18084041   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.